Job changes: Sanofi, AstraZeneca, Novo Nordisk

Job changes: Sanofi, AstraZeneca, Novo Nordisk

20-Oct-2014 - Sanofi has hired an ex-AstraZeneca president as its General Manager for the UK and Ireland.Tarja Stenvall was previously Country President for AstraZeneca Belgium and Luxembourg,...

API hubs expected to emerge in "second wave" countries says RNCOS CEO

Quality probs and rising wages will see new API hubs replace China and India says analyst

20-Oct-2014 - Analysts predicting a second wave of global API hubs say it will be hard for manufacturers in Latin America, Ukraine and Taiwan to avoid the pitfalls that stymied former high growth sectors in Asia.

Health Canada will allow import of 42 'critical' drugs depending on independent quality tests

Canada issues licenses for critical drugs hit by Apotex/IPCA import alert

20-Oct-2014 - Over forty “necessary products” made at Apotex and IPCA facilities hit with an import alert can be sold in Canada after regulators took steps to prevent shortages.

Eli Lilly plans to close and sell one its Guayama, Puerto Rico plant

Eli Lilly to sell PR plant due to patent expirations and shifting portfolio

20-Oct-2014 - Eli Lilly is set to close one of its Puerto Rican facilities as patent expirations and a shifting portfolio reduce its need for capacity.

AbbVie-Shire megamerger unlikely to happen following U-turn in the boardroom

AbbVie leaves $50bn Shire deal for dead following US tax rule changes

16-Oct-2014 - AbbVie’s proposed £31bn ($50bn) takeover of Shire is very likely “dead” after the US biopharma's board changed its recommendation and advised shareholders not to back the bid.

PDPs attracting Big Pharma in Brazil says Jose Piccolotto, head of business development at Brazil's largest drugmaker EMS

Big Pharmas and API suppliers eyeing Brazilian Government deals says EMS

16-Oct-2014 - Government contracts guaranteeing market share in Brazil are starting to attract innovators like Roche, Novartis and Sanofi and may see API suppliers get long-term work according to a spokesman for Sao Bernardo do Campo-based drugmaker, EMS.

Nuclear Magnetic Resonance business no more for Agilent

Agilent to close NMR unit with loss of 300 jobs

15-Oct-2014 - Agilent Technologies is to exit its Nuclear Magnetic Resonance (NMR) business because it has not met growth and profit targets.

Dr Domenico di Giorgio, AIFA at EDQM conf in Strasbourg last week

Food supplements are Europe's real counterfeit drug problem says AIFA expert

15-Oct-2014 - Drug active ingredients in food supplements are Europe’s real falsified medicines problem according to the head of AIFA’s counterfeit prevention team.

Indian Government compares recent success in its cut-price mission to Mars to drug manufacturing

Global regulators demanding needless drug quality levels, says Indian Gov

15-Oct-2014 - Overzealous and unnecessary quality demands by some regulatory agencies are driving up the cost of medicines, according to the Indian Government.

Biohazard four lab needed to work with Ebola virus

Free trade and strong IP held back Ebola vaccine development says NGO

15-Oct-2014 - The lack of an Ebola vaccine decades after the virus was discovered is due in part to IP protections in trade deals like TTIP that discourage innovation according to NGO, Health Action International (HAI).

Got questions for AstraZeneca and Pfizer in Sweden? submit them here

Got questions for AstraZeneca and Pfizer in Sweden? submit them here

15-Oct-2014 -   [View the story "Hej Sweden: in-Pharmatechnologist talks production strategy with AstraZeneca and Pfizer" on Storify]

DSM makes statins like rosuvastatin, the API in Astrazeneca's Crestor, using enzymes

DSM cuts out China's ATS-8 intermediate middlemen with enzyme-made statin APIs

14-Oct-2014 - Royal DSM has launched a statin API it claims is made using a green production method that reduces reliance on intermediate suppliers.

There is a shortage of aseptic capacity in the UK following issues at SCM pharma and capability U-turns, says Aesica

CDMOs: Leave aseptic manufacturing to the Vetters of this world, says Aesica

14-Oct-2014 - Aesica has turned its back on sterile injectables manufacturing and, in an exclusive interview, told Outsourcing-Pharma.com there is now limited steriles capability in the UK following the exit of other key players. 

EDQM conference took place at the Palace of Europe in Strasbourg, France last week

IPEC calls for inclusion of excipient compound monographs in Ph. Eur.

14-Oct-2014 - 'Excipient compound' monographs should be included in the European Pharmacopoeia according to IPEC, which argues they would help manufacturers and promote acceptance of the standards outside Europe.

US OK for Gilead's HCV combo

US FDA approves Gilead's $1,125 a pill combination Hep C drug

14-Oct-2014 - Gilead says its hepatitis C combination drug Harvoni will deliver significant healthcare savings in the long-term despite its $1,150 (€885) a pill price tag.

Dr. Graham Cook,  Sr. Director, Pfizer Global Quality Strategy speaking at EDQM 50th anniversary conference in Strasbourg

Drug complexity will change how Big Pharma uses Ph. Eur. says Pfizer expert

13-Oct-2014 - Growing drug complexity will soon make the European pharmacopoeia’s general chapters more valuable to innovative drugmakers than individual monographs according to Pfizer quality and compendial affairs expert, Graham Cook. 

Halal: not just about food (Picture: Marco Bellucci/Flickr)

Halal: accessing the untapped $30bn pharma market

13-Oct-2014 - The pharmaceutical industry must change its ingredients and manufacturing methods to cash in on the enormous purchasing power of European Muslims, says an expert.

Capsugel site in Colmar, France

Capsugel’s French and Belgian Sites Receive EXCiPACT Certification

13-Oct-2014 - The auditing company, SGS, recently certified that Capsugel’s manufacturing sites in Colmar, France and Bornem, Belgium meet Good Manufacturing Practice (GMP) standards set by EXCiPACT for pharmaceutical excipients manufacturing.

Center for Innovation in Advanced Development and Manufacturing medical Countermeasures in Texas

Texas A&M licenses Xoma mobile clean room tech citing cost savings and flexibility

10-Oct-2014 - US academics have licensed a mobile clean room design from Xoma for a vaccine and medical countermeasure plant being built in Texas as part of an HHS-funded project.

Highly potent APIs: can lean manufacturing ever be safe?

Highly potent APIs: can lean manufacturing ever be safe?

09-Oct-2014 - The phrase “lean manufacturing” conjures up job cuts and not much more for many people, but managers can use the method to drastically simplify HPAPI (highly potent active pharmaceutical ingredients) production, says an expert.